Likewise, the APOE ε4 allele is a major genetic risk for AD, affecting microglial activation, neuroinflammation, and Aβ deposition, reinforcing the essential contribution of genetic control to microglial functions (Wolfe et al. 2018; Ferrari-Souza et al. 2023). The gene discussed is APOE; the disease is Alzheimer disease.